Biogen (BIIB) Change in Intangibles (2011 - 2025)

Biogen (BIIB) posted quarterly Change in Intangibles of $16.3 million for Q4 2025, up 8.67% year-over-year from $15.0 million in Q4 2024, and up 207.55% on a QoQ basis from $5.3 million in Q3 2025.

Biogen (BIIB) Change in Intangibles (2011 - 2025) Analysis & Trends

Biogen (BIIB) has reported Change in Intangibles for 14 consecutive years, with $16.3 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Change in Intangibles rose 8.67% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $21.6 million (down 83.27% YoY), while the FY2025 annual figure was $31.6 million, down 84.67% from the prior year.
  • Change in Intangibles came in at $16.3 million for Q4 2025 at Biogen, up from $5.3 million in the prior quarter.
  • The five-year high for Change in Intangibles was $95.0 million in Q3 2024, with the low at $1.0 million in Q4 2022.
  • Average Change in Intangibles over 5 years is $20.1 million, with a median of $11.7 million recorded in 2023.
  • Across the five-year window, Change in Intangibles surged 1400.0% in 2024 and plunged 94.42% in 2025, its largest moves.
  • Year by year, Change in Intangibles stood at $16.9 million in 2021, then slumped by 94.08% to $1.0 million in 2022, then soared by 1240.0% to $13.4 million in 2023, then gained by 11.94% to $15.0 million in 2024, then increased by 8.67% to $16.3 million in 2025.
  • According to Business Quant data, Change in Intangibles over the past three periods registered $16.3 million, $5.3 million, and $10.0 million for Q4 2025, Q3 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -991.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -461.00 Mn
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 16.30 Mn
Dec 31, 2025 16.30 Mn
Sep 30, 2025 5.30 Mn
Sep 30, 2025 5.30 Mn
Mar 31, 2025 10.00 Mn
Mar 31, 2025 10.00 Mn
Dec 31, 2024 15.00 Mn
Dec 31, 2024 15.00 Mn
Sep 30, 2024 95.00 Mn
Sep 30, 2024 95.00 Mn
Jun 30, 2024 9.10 Mn
Jun 30, 2024 9.10 Mn
Mar 31, 2024 75.00 Mn
Mar 31, 2024 75.00 Mn
Sep 30, 2023 13.40 Mn
Sep 30, 2023 13.40 Mn
Jun 30, 2023 16.00 Mn
Jun 30, 2023 16.00 Mn
Mar 31, 2023 5.00 Mn
Mar 31, 2023 5.00 Mn